Véronique Vergé

469 citations
20 papers · 125 indexed · h-index 6
Topics
CAR-T cell therapy research (8 papers)Immune Cell Function and Interaction (5 papers)Lymphoma Diagnosis and Treatment (5 papers)

In The Last Decade

Véronique Vergé

16 papers receiving 123 citations

Peers

Véronique Vergé
Comparison fields: 5 of 28
  • Immunology 81
  • Molecular Biology 47
  • Oncology 40
  • Hematology 21
  • Pathology and Forensic Medicine 12
Replace Kenichi Ishiyama with:
Kenichi Ishiyama Japan
Ilse Houtenbos Netherlands
Chonghai Liu Sweden
Suet Ling Felce United Kingdom
Elena M. Cortizas United States
John C. Byrd United States
Thomas Altmann United Kingdom
Jim Houston United States
Natasha Silke Australia
Julia Steinbacher Germany
Véronique Vergé relative to Kenichi Ishiyama Japan Kenichi Ishiyama's profile →
Citations per field
00.5×1.6×
Kenichi Ishiyama · 1×
Citations per year

Countries citing papers authored by Véronique Vergé

Since Specialization
Citations

This map shows the geographic impact of Véronique Vergé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Vergé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Vergé more than expected).

Fields of papers citing papers by Véronique Vergé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Vergé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Vergé. The network helps show where Véronique Vergé may publish in the future.

Co-authorship network of co-authors of Véronique Vergé

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Vergé. A scholar is included among the top collaborators of Véronique Vergé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Vergé. Véronique Vergé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 2
5 2
6 1
7 5
8 7
9 2
10 1
11 1
12 2
13 0
14 0
15 2
16 1
17 24
18 43
19 9
20 20

About Véronique Vergé

Véronique Vergé is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine, having authored 20 papers that have together received 125 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Immunology (81 citations), Hematology (21 citations) and Oncology (40 citations). Véronique Vergé has collaborated with scholars based in France, United States and Lebanon. Frequent co-authors include Suzy Scholl, Norbert Claude Gorin, M. Lopez, Hua Cao, Jean Salamero, A. Léon, Chantal Martinache, Carole Baron, Jacky Bernard and Jean‐Marc Bertho. Their work appears in journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026